Epigenetic Reprogramming by Mycobacterium tuberculosis Secretory Proteins: Implications for Pathogenesis and Therapy.

Area of Science:

• Immunology
• Molecular Biology
• Epigenetics

Background:

• Mycobacterium tuberculosis (Mtb) poses a global health threat due to immune modulation and persistence.
• Epigenetic reprogramming is a key mechanism Mtb uses to alter host cell function without changing DNA.
• Mtb secretory proteins act as nucleomodulins, directly targeting host chromatin to control gene expression.

Purpose of the Study:

• To review how Mtb secretory proteins function as nucleomodulins.
• To elucidate the mechanisms of Mtb-mediated epigenetic reprogramming in host cells.
• To explore the therapeutic potential of targeting host epigenetic modifications.

Main Methods:

• Review of Mtb secretion systems (ESX, SecA2) for effector protein delivery.
• Analysis of nucleomodulin interactions with host chromatin.
• Examination of epigenetic modifications (histone methylation, DNA methylation, histone acetylation).

Main Results:

• Mtb nucleomodulins induce epigenetic changes, reprogramming immune-related genes.
• These modifications impair host defense mechanisms like macrophage activation and cytokine production.
• Epigenetic remodeling influences macrophage polarization and metabolism, impacting disease progression.

Conclusions:

• Mtb nucleomodulins are crucial for bacterial survival by manipulating host epigenetics.
• Epigenetic modifications are reversible, offering therapeutic targets.
• Targeting host epigenetic enzymes shows promise for enhancing tuberculosis treatment, especially with conventional therapies.